1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analysts (LPAs), Stephanie Torres and Cheryl Goodrich, conducted an unannounced visit to the facility to start the investigation into the above allegation. The LPAs met with Business Office Manager, Lucia Gutierrez, and informed her of the purpose of the visit.
The LPA conducted staff/resident interviews, reviewed records, and took copies of relevant documentation.
Regarding the allegation, "Staff prohibiting resident from having PRN medication at the facility," it was alleged facility staff required an agency, who was contracted to provide healthcare services to Resident One (R1), to discontinue PRN (Pro Re Nata) medications. Interviews revealed R1 is contracted to receive services from an outside agency. Interviews revealed the facility did request the outside agency of R1 to discontinue unused PRN medications that have remained unused for two months. Executive Director (ED), Kameshi Taylor, was interviewed and confirmed the facility did request outside agencies to no longer store medications not being regularly used by residents in care. Taylor denied requiring outside agencies to remove the medication without |